NVO DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – NVO
March 21, 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Novo Nordisk […]